New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer

REFERENCES

• American Cancer Society . 2010 . Cancer Facts and Figures 2010 , Atlanta , GA : American Cancer Society .
   Google Scholar
• Bostwick , D G and Qian , J . 2004 . High-grade prostatic intraepithelial neoplasia . Mod Pathol , 17 : 360 – 379 .
   PubMed Web of Science ®Google Scholar
• Epstein , J I and Herawi , M . 2006 . Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care . J Urol , 175 : 820 – 834 .
   PubMed Web of Science ®Google Scholar
• Kraft , A , Weindel , K , Ochs , A , Marth , C and Zmija , J . 1999 . Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease . Cancer , 85 : 178 – 187 .
   PubMed Web of Science ®Google Scholar
• Mohamed , M A , Greif , P A , Diamond , J , Sharaf , O and Maxwell , P . 2007 . Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma . BJU Int , 99 : 908 – 915 .
   PubMed Web of Science ®Google Scholar
• Giovannuci , E . 1995 . Epidemiologic characteristics of prostate cancer . Cancer , 75 : 1766 – 1777 .
   Web of Science ®Google Scholar
• Johnson , J J , Bailey , H H and Mukhtar , H . 2010 . Green tea polyphenols for prostate cancer chemoprevention: a translational perspective . Phytomedicine , 17 : 3 – 13 .
   PubMed Web of Science ®Google Scholar
• Wynder , E L , Rose , D P and Cohen , L A . 1994 . Nutrition and prostate cancer: a proposal for dietary intervention . Nutr Cancer , 22 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Jian , L , Xie , L P , Lee , A H and Binns , C W . 2004 . Protective effect of green tea against prostate cancer: a case-control study in southeast China . Int J Cancer , 108 : 130 – 135 .
   PubMed Web of Science ®Google Scholar
• Nelson , W G . 2004 . Agents in development for prostate cancer prevention . Expert Opin Investig Drugs , 13 : 1541 – 1554 .
   PubMed Web of Science ®Google Scholar
• Division of Cancer Prevention and Control . 1996 . Clinical development plan: tea extracts, green tea polyphenols, epigallocatechin gallate . J Cell Biochem , 26 : 236 – 257 .
   Google Scholar
• Balentine , D A , Wiseman , S A and Bouwens , L C . 1997 . The chemistry of tea flavonoids . Crit Rev Food Sci Nutr , 37 : 693 – 704 .
   PubMed Web of Science ®Google Scholar
• Ahn , W S , Yoo , J , Huh , S W , Kim , C K and Lee , J M . 2003 . Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions . Eur J Cancer Prev , 12 : 383 – 390 .
   PubMed Web of Science ®Google Scholar
• Bushman , J L . 1998 . Green tea and cancer in humans: a review of the literature . Nutr Cancer , 31 : 151 – 159 .
   PubMed Web of Science ®Google Scholar
• Higdon , J V and Frei , B . 2003 . Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions . Crit Rev Food Sci Nutr , 43 : 89 – 143 .
   PubMed Web of Science ®Google Scholar
• Kelloff , G J , Boone , C W , Crowell , J A , Nayfield , S G and Hawk , E . 1996 . Risk biomarkers and current strategies for cancer chemoprevention . J Cell Biochem Suppl , 25 : 1 – 14 .
   PubMedGoogle Scholar
• Yang , C S , Lambert , J D , Ju , J , Lu , G and Sang , S . 2007 . Tea and cancer prevention: molecular mechanisms and human relevance . Toxicol Appl Pharmacol , 224 : 265 – 273 .
   PubMed Web of Science ®Google Scholar
• Borrelli , F , Capasso , R , Russo , A and Ernst , E . 2004 . Systematic review: green tea and gastrointestinal cancer risk . Aliment Pharmacol Ther , 19 : 497 – 510 .
   PubMed Web of Science ®Google Scholar
• Lambert , J D and Yang , C S . 2003 . Cancer chemopreventive activity and bioavailability of tea and tea polyphenols . Mutat Res , 523–524 : 201 – 208 .
   PubMed Web of Science ®Google Scholar
• Liang , W , Binns , C W , Jian , L and Lee , A H . 2007 . Does the consumption of green tea reduce the risk of lung cancer among smokers? . Evid Based Complement Alternat Med , 4 : 17 – 22 .
   PubMed Web of Science ®Google Scholar
• Sun , C L , Yuan , J M , Koh , W P and Yu , M C . 2006 . Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies . Carcinogenesis , 27 : 1310 – 1315 .
   PubMed Web of Science ®Google Scholar
• Woolcott , C G , King , W D and Marrett , L D . 2002 . Coffee and tea consumption and cancers of the bladder, colon and rectum . Eur J Cancer Prev , 11 : 137 – 145 .
   PubMed Web of Science ®Google Scholar
• Kumar , N , Titus-Ernstoff , L , Newcomb , P A , Trentham-Dietz , A and Anic , G . 2009 . Tea consumption and risk of breast cancer . Cancer Epidemiol Biomarkers Prev , 18 : 341 – 345 .
   PubMed Web of Science ®Google Scholar
• Chow , H H , Hakim , I A , Vining , D R , Crowell , J A and Cordova , C A . 2006 . Effects of repeated green tea catechin administration on human cytochrome P450 activity . Cancer Epidemiol Biomarkers Prev , 15 : 2473 – 2476 .
   PubMed Web of Science ®Google Scholar
• Lee , M J , Maliakal , P , Chen , L , Meng , X and Bondoc , F Y . 2002 . Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability . Cancer Epidemiol Biomarkers Prev , 11 : 1025 – 1032 .
   PubMed Web of Science ®Google Scholar
• Weinshilboum , R M , Otterness , D M and Szumlanski , C L . 1999 . Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase . Annu Rev Pharmacol Toxicol , 39 : 19 – 52 .
   PubMed Web of Science ®Google Scholar
• Mukhtar , H and Ahmad , N . Tea polyphenols: prevention of cancer and optimizing health . Am J Clin Nutr , 71 1698S – 1702S . discussion, 1703S–1694S, 2000
   PubMed Web of Science ®Google Scholar
• Sang , S , Lambert , J D , Ho , C T and Yang , C S . 2011 . The chemistry and biotransformation of tea constituents . Pharmacol Res , 64 : 87 – 99 .
   PubMed Web of Science ®Google Scholar
• Yuan , J M , Sun , C and Butler , L M . 2011 . Chapter 8. Tea and cancer prevention: epidemiological studies . Pharmacol Res , 64 : 123 – 135 .
   PubMed Web of Science ®Google Scholar
• Thakur , V S , Gupta , K and Gupta , S . 2011 . The chemopreventive and chemotherapeutic potentials of tea polyphenols . Curr Pharm Biotechnol , Epub ahead of print April 5,
   Web of Science ®Google Scholar
• Hamilton-Miller , J M . 1995 . Antimicrobial properties of tea (Camellia sinensis L.) . Antimicrob Agents Chemother , 39 : 2375 – 2377 .
   PubMed Web of Science ®Google Scholar
• Katiyar , S and Mukhtar , H . 1996 . Tea in chemoprevention of cancer: epidemiologic and experimental studies . Int J Oncol , 8 : 221 – 238 .
   PubMed Web of Science ®Google Scholar
• Liao , S , Kao , YH. and Hiipakka , R A . 2001 . Green tea: biochemical and biological basis for health benefits . Vitam Horm , 62 : 1 – 94 .
   PubMed Web of Science ®Google Scholar
• Gullett , N P , Ruhul Amin , AR , Bayraktar , S , Pezzuto , J M and Shin , D M . 2010 . Cancer prevention with natural compounds . Semin Oncol , 37 : 258 – 281 .
   PubMed Web of Science ®Google Scholar
• Kelloff , G J , Lieberman , R , Steele , V E , Boone , C W and Lubet , R A . 2001 . Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer . Urology , 57 : 46 – 51 .
   PubMed Web of Science ®Google Scholar
• Dou , Q P . 2009 . Molecular mechanisms of green tea polyphenols . Nutr Cancer , 61 : 827 – 835 .
   PubMed Web of Science ®Google Scholar
• Greenwald , P and Kelloff , G J . 1996 . The role of chemoprevention in cancer control . IARC Sci Publ , : 13 – 22 .
   PubMedGoogle Scholar
• Khan , N , Adhami , V M and Mukhtar , H . 2009 . Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies . Nutr Cancer , 61 : 836 – 841 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Hastak , K , Ahmad , N , Lewin , J S and Mukhtar , H . 2001 . Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols . Proc Natl Acad Sci USA , 98 : 10350 – 10355 .
   PubMed Web of Science ®Google Scholar
• Greenwald , P . 2004 . Clinical trials in cancer prevention: current results and perspectives for the future . J Nutr , 134 : 3507S – 3512S .
   PubMed Web of Science ®Google Scholar
• Khan , N , Afaq , F and Mukhtar , H . 2008 . Cancer chemoprevention through dietary antioxidants: progress and promise . Antioxid Redox Signal , 10 : 475 – 510 .
   PubMed Web of Science ®Google Scholar
• Khan , N and Mukhtar , H . 2007 . Tea polyphenols for health promotion . Life Sci , 81 : 519 – 533 .
   PubMed Web of Science ®Google Scholar
• Chow , H H , Cai , Y , Alberts , D S , Hakim , I and Dorr , R . 2001 . Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E . Cancer Epidemiol Biomarkers Prev , 10 : 53 – 58 .
   PubMed Web of Science ®Google Scholar
• Chow , H H , Cai , Y , Hakim , I A , Crowell , J A and Shahi , F . 2003 . Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals . Clin Cancer Res , 9 : 3312 – 3319 .
   PubMed Web of Science ®Google Scholar
• Chow , H H , Hakim , I A , Vining , D R , Crowell , J A and Ranger-Moore , J . 2005 . Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals . Clin Cancer Res , 11 : 4627 – 4633 .
   PubMed Web of Science ®Google Scholar
• Ullmann , U , Haller , J , Decourt , J D , Girault , J and Spitzer , V . 2004 . Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers . Int J Vitam Nutr Res , 74 : 269 – 278 .
   PubMed Web of Science ®Google Scholar
• Ullmann , U , Haller , J , Decourt , J P , Girault , N and Girault , J . 2003 . A single ascending dose study of epigallocatechin gallate in healthy volunteers . J Int Med Res , 31 : 88 – 101 .
   PubMed Web of Science ®Google Scholar
• Ahmad , N , Feyes , D K , Nieminen , A L , Agarwal , R and Mukhtar , H . 1997 . Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells . J Natl Cancer Inst , 89 : 1881 – 1886 .
   PubMed Web of Science ®Google Scholar
• Ahmad , N , Gupta , S and Mukhtar , H . 2000 . Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells . Arch Biochem Biophys , 376 : 338 – 346 .
   PubMed Web of Science ®Google Scholar
• Albrecht , D S , Clubbs , E A , Ferruzzi , M and Bomser , J A . 2008 . Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation . Chem Biol Interact , 171 : 89 – 95 .
   PubMed Web of Science ®Google Scholar
• Caporali , A , Davalli , P , Astancolle , S , D’Arca , D and Brausi , M . 2004 . The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression . Carcinogenesis , 25 : 2217 – 2224 .
   PubMed Web of Science ®Google Scholar
• Smith , D M , Wang , Z , Kazi , A , Li , L H and Chan , T H . 2002 . Synthetic analogs of green tea polyphenols as proteasome inhibitors . Mol Med , 8 : 382 – 392 .
   PubMed Web of Science ®Google Scholar
• Sartippour , M R , Shao , Z M , Heber , D , Beatty , P and Zhang , L . 2002 . Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells . J Nutr , 132 : 2307 – 2311 .
   PubMed Web of Science ®Google Scholar
• Hsu , A , Bruno , R S , Lohr , C V , Taylor , A W and Dashwood , R H . 2010 . Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFkappaB pathway in the Noble rat model . J Nutr Biochem , 22 : 502 – 510 .
   Web of Science ®Google Scholar
• Nair , S , Barve , A , Khor , T O , Shen , G X and Lin , W . 2010 . Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells . Acta Pharmacol Sin , 31 : 1223 – 1240 .
   PubMed Web of Science ®Google Scholar
• Zhou , J R , Yu , L , Zhong , Y and Blackburn , G L . 2003 . Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice . J Nutr , 133 : 516 – 521 .
   PubMed Web of Science ®Google Scholar
• Chen , X , Yu , H , Shen , S and Yin , J . 2007 . Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells . J Trace Elem Med Biol , 21 : 125 – 131 .
   PubMed Web of Science ®Google Scholar
• Roomi , M W , Ivanov , V , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2005 . In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry . In Vivo , 19 : 179 – 183 .
   PubMed Web of Science ®Google Scholar
• Yu , H N , Yin , J J and Shen , S R . 2004 . Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+ . J Agric Food Chem , 52 : 462 – 466 .
   PubMed Web of Science ®Google Scholar
• Morrissey , C , Brown , M , O’Sullivan , J , Weathered , N and Watson , R W . 2007 . Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells . Int J Urol , 14 : 545 – 551 .
   PubMed Web of Science ®Google Scholar
• Adhami , V M , Malik , A , Zaman , N , Sarfaraz , S and Siddiqui , I A . 2007 . Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo . Clin Cancer Res , 13 : 1611 – 1619 .
   PubMed Web of Science ®Google Scholar
• Fujiki , H . 1999 . Two stages of cancer prevention with green tea . J Cancer Res Clin Oncol , 125 : 589 – 597 .
   PubMed Web of Science ®Google Scholar
• Chen , L , Lee , M J , Li , H and Yang , C S . 1997 . Absorption, distribution, elimination of tea polyphenols in rats . Drug Metab Dispos , 25 : 1045 – 1050 .
   PubMed Web of Science ®Google Scholar
• Moyers , S B and Kumar , N B . 2004 . Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials . Nutr Rev , 62 : 204 – 211 .
   PubMed Web of Science ®Google Scholar
• Paschka , A G , Butler , R and Young , C Y . 1998 . Induction of apoptosis in prostate cancer cell lines by the green tea component, (−)-epigallocatechin-3-gallate . Cancer Lett , 130 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Suganuma , M , Okabe , S , Sueoka , N , Sueoka , E and Matsuyama , S . 1999 . Green tea and cancer chemoprevention . Mutat Res , 428 : 339 – 344 .
   PubMed Web of Science ®Google Scholar
• Pisters , K M , Newman , R A , Coldman , B , Shin , D M and Khuri , F R . 2001 . Phase I trial of oral green tea extract in adult patients with solid tumors . J Clin Oncol , 19 : 1830 – 1838 .
   PubMed Web of Science ®Google Scholar
• Choan , E , Segal , R , Jonker , D , Malone , S and Reaume , N . 2005 . A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach . Urol Oncol , 23 : 108 – 113 .
   PubMed Web of Science ®Google Scholar
• Jatoi , A , Ellison , N , Burch , P A , Sloan , J A and Dakhil , S R . 2003 . A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma . Cancer , 97 : 1442 – 1446 .
   PubMed Web of Science ®Google Scholar
• Bettuzzi , S , Brausi , M , Rizzi , F , Castagnetti , G and Peracchia , G . 2006 . Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study . Cancer Res , 66 : 1234 – 1240 .
   PubMed Web of Science ®Google Scholar
• Brausi , M , Rizzi , F and Bettuzzi , S . 2008 . Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update . Eur Urol , 54 : 472 – 473 .
   PubMed Web of Science ®Google Scholar
• McLarty , J , Bigelow , R L , Smith , M , Elmajian , D and Ankem , M . 2009 . Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro . Cancer Prev Res (Phila) , 2 : 673 – 682 .
   PubMed Web of Science ®Google Scholar
• Lee , M J , Wang , Z Y , Li , H , Chen , L and Sun , Y . 1995 . Analysis of plasma and urinary tea polyphenols in human subjects . Cancer Epidemiol Biomarkers Prev , 4 : 393 – 399 .
   PubMed Web of Science ®Google Scholar
• Yang , C S , Chen , L , Lee , M J , Balentine , D and Kuo , M C . 1998 . Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers . Cancer Epidemiol Biomarkers Prev , 7 : 351 – 354 .
   PubMed Web of Science ®Google Scholar
• Yang , C S , Lee , M J and Chen , L . 1999 . Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies . Cancer Epidemiol Biomarkers Prev , 8 : 83 – 89 .
   PubMed Web of Science ®Google Scholar
• Henning , S M , Aronson , W , Niu , Y , Conde , F and Lee , N H . 2006 . Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption . J Nutr , 136 : 1839 – 1843 .
   PubMed Web of Science ®Google Scholar
• Hanahan , D and Weinberg , R A . 2000 . The hallmarks of cancer . Cell , 100 : 57 – 70 .
   PubMed Web of Science ®Google Scholar
• Hanahan , D and Weinberg , R A . 2011 . Hallmarks of cancer: the next generation . Cell , 144 : 646 – 674 .
   PubMed Web of Science ®Google Scholar
• Dou , Q P , Landis-Piwowar , K R , Chen , D , Huo , C and Wan , S B . 2008 . Green tea polyphenols as a natural tumour cell proteasome inhibitor . Inflammopharmacology , 16 : 208 – 212 .
   PubMedGoogle Scholar
• Blagosklonny , M V , Wu , G S , Omura , S and el-Deiry , W S . 1996 . Proteasome-dependent regulation of p21WAF1/CIP1 expression . Biochem Biophys Res Commun , 227 : 564 – 569 .
   PubMed Web of Science ®Google Scholar
• Nicholson , D W , Ali , A , Thornberry , N A , Vaillancourt , J P and Ding , C K . 1995 . Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis . Nature , 376 : 37 – 43 .
   PubMed Web of Science ®Google Scholar
• Verma , I M , Stevenson , J K , Schwarz , E M , Van Antwerp , D and Miyamoto , S . 1995 . Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation . Genes Dev , 9 : 2723 – 2735 .
   PubMed Web of Science ®Google Scholar
• Pagano , M , Tam , S W , Theodoras , A M , Beer-Romero , P and Del Sal , G . 1995 . Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 . Science , 269 : 682 – 685 .
   PubMed Web of Science ®Google Scholar
• Li , B and Dou , Q P . 2000 . Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression . Proc Natl Acad Sci USA , 97 : 3850 – 3855 .
   PubMed Web of Science ®Google Scholar
• Nam , S , Smith , D M and Dou , Q P . 2001 . Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo . J Biol Chem , 276 : 13322 – 13330 .
   PubMed Web of Science ®Google Scholar
• Yang , C S . 1999 . Tea and health . Nutrition , 15 : 946 – 949 .
   PubMed Web of Science ®Google Scholar
• Sandhu , C and Slingerland , J . 2000 . Deregulation of the cell cycle in cancer . Cancer Detect Prev , 24 : 107 – 118 .
   PubMedGoogle Scholar
• Sherr , C J . 1996 . Cancer cell cycles . Science , 274 : 1672 – 1677 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Hussain , T and Mukhtar , H . 2003 . Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells . Arch Biochem Biophys , 410 : 177 – 185 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Ahmad , N , Nieminen , A L and Mukhtar , H . 2000 . Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (−)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells . Toxicol Appl Pharmacol , 164 : 82 – 90 .
   PubMed Web of Science ®Google Scholar
• Dotto , G P . 2000 . p21(WAF1/Cip1): more than a break to the cell cycle? . Biochim Biophys Acta , 1471 : M43 – M56 .
   PubMed Web of Science ®Google Scholar
• Gartel , A L , Serfas , M S and Tyner , A L . 1996 . p21—negative regulator of the cell cycle . Proc Soc Exp Biol Med , 213 : 138 – 149 .
   PubMed Web of Science ®Google Scholar
• Ortega , S , Malumbres , M and Barbacid , M . 2002 . Cyclin D-dependent kinases, INK4 inhibitors and cancer . Biochim Biophys Acta , 1602 : 73 – 87 .
   PubMed Web of Science ®Google Scholar
• Pavletich , N P . 1999 . Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors . J Mol Biol , 287 : 821 – 828 .
   PubMed Web of Science ®Google Scholar
• Hastak , K , Gupta , S , Ahmad , N , Agarwal , M K and Agarwal , M L . 2003 . Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells . Oncogene , 22 : 4851 – 4859 .
   PubMed Web of Science ®Google Scholar
• Brizuela , L , Dayon , A , Doumerc , N , Ader , I and Golzio , M . 2010 . The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer . FASEB J , 24 : 3882 – 3894 .
   PubMed Web of Science ®Google Scholar
• Brusselmans , K , De Schrijver , E , Heyns , W , Verhoeven , G and Swinnen , J V . 2003 . Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells . Int J Cancer , 106 : 856 – 862 .
   PubMed Web of Science ®Google Scholar
• Chung , L Y , Cheung , T C , Kong , S K , Fung , K P and Choy , Y M . 2001 . Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells . Life Sci , 68 : 1207 – 1214 .
   PubMed Web of Science ®Google Scholar
• Chuu , C P , Chen , R Y , Kokontis , J M , Hiipakka , R A and Liao , S . 2009 . Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells . Cancer Lett , 275 : 86 – 92 .
   PubMed Web of Science ®Google Scholar
• Hussain , T , Gupta , S , Adhami , V M and Mukhtar , H . 2005 . Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells . Int J Cancer , 113 : 660 – 669 .
   PubMed Web of Science ®Google Scholar
• Lyn-Cook , B D , Rogers , T , Yan , Y , Blann , E B and Kadlubar , F F . 1999 . Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro . Nutr Cancer , 35 : 80 – 86 .
   PubMed Web of Science ®Google Scholar
• Pezzato , E , Sartor , L , Dell’Aica , I , Dittadi , R and Gion , M . 2004 . Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (−)epigallocatechin-3-gallate . Int J Cancer , 112 : 787 – 792 .
   PubMed Web of Science ®Google Scholar
• Ravindranath , M H , Saravanan , T S , Monteclaro , C C , Presser , N and Ye , X . 2006 . Epicatechins purified from green tea (Camellia sinensis) differentially suppress growth of gender-dependent human cancer cell lines . Evid Based Complement Alternat Med , 3 : 237 – 247 .
   PubMed Web of Science ®Google Scholar
• Ren , F , Zhang , S , Mitchell , S H , Butler , R and Young , C Y . 2000 . Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells . Oncogene , 19 : 1924 – 1932 .
   PubMed Web of Science ®Google Scholar
• Thomas , F , Patel , S , Holly , J M , Persad , R and Bahl , A . 2009 . Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor . Prostate , 69 : 219 – 224 .
   PubMed Web of Science ®Google Scholar
• Sartor , L , Pezzato , E , Dona , M , Dell’Aica , I and Calabrese , F . 2004 . Prostate carcinoma and green tea: (−)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model . Int J Cancer , 112 : 823 – 829 .
   PubMed Web of Science ®Google Scholar
• Pandey , M , Shukla , S and Gupta , S . 2010 . Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells . Int J Cancer , 126 : 2520 – 2533 .
   PubMed Web of Science ®Google Scholar
• Harper , C E , Patel , B B , Wang , J , Eltoum , I A and Lamartiniere , C A . 2007 . Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action . Prostate , 67 : 1576 – 1589 .
   PubMed Web of Science ®Google Scholar
• McCarthy , S , Caporali , A , Enkemann , S , Scaltriti , M and Eschrich , S . 2007 . Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer . Mol Oncol , 1 : 196 – 204 .
   PubMed Web of Science ®Google Scholar
• Nyska , A , Suttie , A , Bakshi , S , Lomnitski , L and Grossman , S . 2003 . Slowing tumorigenic progression in TRAMP mice and prostatic carcinoma cell lines using natural antioxidant from spinach, NAO—a comparative study of three anti-oxidants . Toxicol Pathol , 31 : 39 – 51 .
   PubMed Web of Science ®Google Scholar
• Liao , S , Umekita , Y , Guo , J , Kokontis , J M and Hiipakka , R A . 1995 . Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate . Cancer Lett , 96 : 239 – 243 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Zaman , N , Aziz , M H , Reagan-Shaw , S R and Sarfaraz , S . 2006 . Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas . Carcinogenesis , 27 : 833 – 839 .
   PubMed Web of Science ®Google Scholar
• Kao , Y H , Hiipakka , R A and Liao , S . 2000 . Modulation of endocrine systems and food intake by green tea epigallocatechin gallate . Endocrinology , 141 : 980 – 987 .
   PubMed Web of Science ®Google Scholar
• Hiipakka , R A , Zhang , H Z , Dai , W , Dai , Q and Liao , S . 2002 . Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols . Biochem Pharmacol , 63 : 1165 – 1176 .
   PubMed Web of Science ®Google Scholar
• Liao , S and Hiipakka , R A . 1995 . Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate . Biochem Biophys Res Commun , 214 : 833 – 838 .
   PubMed Web of Science ®Google Scholar
• Balk , S P , Ko , Y J and Bubley , G J . 2003 . Biology of prostate-specific antigen . J Clin Oncol , 21 : 383 – 391 .
   PubMed Web of Science ®Google Scholar
• Christensson , A and Lilja , H . 1994 . Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen . Eur J Biochem , 220 : 45 – 53 .
   PubMedGoogle Scholar
• Wolf , D A , Schulz , P and Fittler , F . 1992 . Transcriptional regulation of prostate kallikrein-like genes by androgen . Mol Endocrinol , 6 : 753 – 762 .
   PubMed Web of Science ®Google Scholar
• Catalona , W J , Richie , J P , Ahmann , F R , Hudson , M A and Scardino , P T . 1994 . Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men . J Urol , 151 : 1283 – 1290 .
   PubMed Web of Science ®Google Scholar
• Lokeshwar , B L . 1999 . MMP inhibition in prostate cancer . Ann NY Acad Sci , 878 : 271 – 289 .
   PubMed Web of Science ®Google Scholar
• Rosenzweig , S A and Atreya , H S . 2010 . Defining the pathway to insulin-like growth factor system targeting in cancer . Biochem Pharmacol , 80 : 1115 – 1124 .
   PubMed Web of Science ®Google Scholar
• Weroha , S J and Haluska , P . 2008 . IGF-1 receptor inhibitors in clinical trials—early lessons . J Mammary Gland Biol Neoplasia , 13 : 471 – 483 .
   PubMed Web of Science ®Google Scholar
• Yu , H and Rohan , T . 2000 . Role of the insulin-like growth factor family in cancer development and progression . J Natl Cancer Inst , 92 : 1472 – 1489 .
   PubMed Web of Science ®Google Scholar
• Adhami , V M , Siddiqui , I A , Ahmad , N , Gupta , S and Mukhtar , H . 2004 . Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer . Cancer Res , 64 : 8715 – 8722 .
   PubMed Web of Science ®Google Scholar
• Kaplan , P J , Mohan , S , Cohen , P , Foster , B A and Greenberg , N M . 1999 . The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model . Cancer Res , 59 : 2203 – 2209 .
   PubMed Web of Science ®Google Scholar
• Li , M , He , Z , Ermakova , S , Zheng , D and Tang , F . 2007 . Direct inhibition of insulin-like growth factor-I receptor kinase activity by (−)-epigallocatechin-3-gallate regulates cell transformation . Cancer Epidemiol Biomarkers Prev , 16 : 598 – 605 .
   PubMed Web of Science ®Google Scholar
• Adhami , V M , Siddiqui , I A , Sarfaraz , S , Khwaja , S I and Hafeez , B B . 2009 . Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease . Clin Cancer Res , 15 : 1947 – 1953 .
   PubMed Web of Science ®Google Scholar
• Arnold , J T and Isaacs , J T . 2002 . Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault . Endocr Relat Cancer , 9 : 61 – 73 .
   PubMed Web of Science ®Google Scholar
• Debes , J D and Tindall , D J . 2004 . Mechanisms of androgen-refractory prostate cancer . N Engl J Med , 351 : 1488 – 1490 .
   PubMed Web of Science ®Google Scholar
• Lee , E C and Tenniswood , M . 2004 . Programmed cell death and survival pathways in prostate cancer cells . Arch Androl , 50 : 27 – 32 .
   PubMed Web of Science ®Google Scholar
• Ferreira , C G , Epping , M , Kruyt , F A and Giaccone , G . 2002 . Apoptosis: target of cancer therapy . Clin Cancer Res , 8 : 2024 – 2034 .
   PubMed Web of Science ®Google Scholar
• Penn , L Z . 2001 . Apoptosis modulators as cancer therapeutics . Curr Opin Investig Drugs , 2 : 684 – 692 .
   PubMedGoogle Scholar
• Gupta , S , Hastak , K , Afaq , F , Ahmad , N and Mukhtar , H . 2004 . Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis . Oncogene , 23 : 2507 – 2522 .
   PubMed Web of Science ®Google Scholar
• Luo , K L , Luo , J H and Yu , Y P . 2010 . (−)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix protein . Cancer Sci , 101 : 707 – 712 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Malik , A , Adhami , V M , Asim , M and Hafeez , B B . 2008 . Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis . Oncogene , 27 : 2055 – 2063 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Adhami , V M , Afaq , F , Ahmad , N and Mukhtar , H . 2004 . Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells . J Cell Biochem , 91 : 232 – 242 .
   PubMed Web of Science ®Google Scholar
• Kazi , A , Smith , D M , Zhong , Q and Dou , Q P . 2002 . Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis . Mol Pharmacol , 62 : 765 – 771 .
   PubMed Web of Science ®Google Scholar
• Alenzi , F Q . 2004 . Links between apoptosis, proliferation and the cell cycle . Br J Biomed Sci , 61 : 99 – 102 .
   PubMed Web of Science ®Google Scholar
• Clarke , P R and Allan , L A . 2009 . Cell-cycle control in the face of damage—a matter of life or death . Trends Cell Biol , 19 : 89 – 98 .
   PubMed Web of Science ®Google Scholar
• Maddika , S , Ande , S R , Panigrahi , S , Paranjothy , T and Weglarczyk , K . 2007 . Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy . Drug Resist Updat , 10 : 13 – 29 .
   PubMed Web of Science ®Google Scholar
• Pucci , B , Kasten , M and Giordano , A . 2000 . Cell cycle and apoptosis . Neoplasia , 2 : 291 – 299 .
   PubMed Web of Science ®Google Scholar
• Pan , M H , Lin , C C , Lin , J K and Chen , W J . 2007 . Tea polyphenol (−)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling . J Agric Food Chem , 55 : 5030 – 5037 .
   PubMed Web of Science ®Google Scholar
• Suh , J , Payvandi , F , Edelstein , L C , Amenta , P S and Zong , W X . 2002 . Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells . Prostate , 52 : 183 – 200 .
   PubMed Web of Science ®Google Scholar
• Sweeney , C , Li , L , Shanmugam , R , Bhat-Nakshatri , P and Jayaprakasan , V . 2004 . Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate . Clin Cancer Res , 10 : 5501 – 5507 .
   PubMed Web of Science ®Google Scholar
• Jin , R J , Lho , Y , Connelly , L , Wang , Y and Yu , X . 2008 . The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth . Cancer Res , 68 : 6762 – 6769 .
   PubMed Web of Science ®Google Scholar
• Zhang , L , Altuwaijri , S , Deng , F , Chen , L and Lal , P . 2009 . NF-kappaB regulates androgen receptor expression and prostate cancer growth . Am J Pathol , 175 : 489 – 499 .
   PubMed Web of Science ®Google Scholar
• Bettuzzi , S , Davalli , P , Astancolle , S , Carani , C and Madeo , B . 2000 . Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens . Cancer Res , 60 : 28 – 34 .
   PubMed Web of Science ®Google Scholar
• Leskov , K S , Klokov , D Y , Li , J , Kinsella , T J and Boothman , D A . 2003 . Synthesis and functional analyses of nuclear clusterin, a cell death protein . J Biol Chem , 278 : 11590 – 11600 .
   PubMed Web of Science ®Google Scholar
• Vayalil , P K and Katiyar , S K . 2004 . Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells . Prostate , 59 : 33 – 42 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Shukla , Y , Adhami , V M , Sarfaraz , S and Asim , M . 2008 . Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model . Pharm Res , 25 : 2135 – 2142 .
   PubMed Web of Science ®Google Scholar
• Fuller , K , Wong , B , Fox , S , Choi , Y and Chambers , T J . 1998 . TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts . J Exp Med , 188 : 997 – 1001 .
   PubMed Web of Science ®Google Scholar
• Wong , B R , Josien , R , Lee , S Y , Sauter , B and Li , H L . 1997 . TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor . J Exp Med , 186 : 2075 – 2080 .
   PubMed Web of Science ®Google Scholar
• Darnay , B G , Ni , J , Moore , P A and Aggarwal , B B . 1999 . Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif . J Biol Chem , 274 : 7724 – 7731 .
   PubMed Web of Science ®Google Scholar
• Gittes , R F . 1991 . Carcinoma of the prostate . N Engl J Med , 324 : 236 – 245 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Ahmad , N , Mohan , R R , Husain , M M and Mukhtar , H . 1999 . Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase . Cancer Res , 59 : 2115 – 2120 .
   PubMed Web of Science ®Google Scholar
• Saleem , M , Adhami , V M , Ahmad , N , Gupta , S and Mukhtar , H . 2005 . Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model . Clin Cancer Res , 11 : 147 – 153 .
   PubMed Web of Science ®Google Scholar
• Teichert , F , Verschoyle , R D , Greaves , P , Jones , D J and Wilson , I D . 2010 . Plasma metabolic profiling reveals age-dependency of systemic effects of green tea polyphenols in mice with and without prostate cancer . Mol Biosyst , 6 : 1911 – 1916 .
   PubMed Web of Science ®Google Scholar
• Mehlen , P and Puisieux , A . 2006 . Metastasis: a question of life or death . Nat Rev Cancer , 6 : 449 – 458 .
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson , W G , Aznavoorian , S and Liotta , L A . 1993 . Tumor cell interactions with the extracellular matrix during invasion and metastasis . Annu Rev Cell Biol , 9 : 541 – 573 .
   PubMed Web of Science ®Google Scholar
• Kleiner , D E and Stetler-Stevenson , W G . 1999 . Matrix metalloproteinases and metastasis . Cancer Chemother Pharmacol , 43 ( Suppl ) : S42 – S51 .
   PubMed Web of Science ®Google Scholar
• Chambers , A F and Matrisian , L M . 1997 . Changing views of the role of matrix metalloproteinases in metastasis . J Natl Cancer Inst , 89 : 1260 – 1270 .
   PubMed Web of Science ®Google Scholar
• John , A and Tuszynski , G . 2001 . The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis . Pathol Oncol Res , 7 : 14 – 23 .
   PubMedGoogle Scholar
• Yu , A E , Hewitt , R E , Connor , E W and Stetler-Stevenson , W G . 1997 . Matrix metalloproteinases. Novel targets for directed cancer therapy . Drugs Aging , 11 : 229 – 244 .
   PubMed Web of Science ®Google Scholar
• Festuccia , C , Dolo , V , Guerra , F , Violini , S and Muzi , P . 1998 . Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells . Clin Exp Metastasis , 16 : 513 – 528 .
   PubMed Web of Science ®Google Scholar
• Sheng , S . 2001 . The urokinase-type plasminogen activator system in prostate cancer metastasis . Cancer Metastasis Rev , 20 : 287 – 296 .
   PubMed Web of Science ®Google Scholar
• Eatock , M M , Schatzlein , A and Kaye , S B . 2000 . Tumour vasculature as a target for anticancer therapy . Cancer Treat Rev , 26 : 191 – 204 .
   PubMed Web of Science ®Google Scholar
• Fox , S B , Gasparini , G and Harris , A L . 2001 . Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs . Lancet Oncol , 2 : 278 – 289 .
   PubMed Web of Science ®Google Scholar
• Kerbel , R S . 2008 . Tumor angiogenesis . N Engl J Med , 358 : 2039 – 2049 .
   PubMed Web of Science ®Google Scholar
• Duque , J L , Loughlin , K R , Adam , R M , Kantoff , P W and Zurakowski , D . 1999 . Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer . Urology , 54 : 523 – 527 .
   PubMed Web of Science ®Google Scholar
• Jones , A , Fujiyama , C , Turner , K , Fuggle , S and Cranston , D . 2000 . Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer . BJU Int , 85 : 276 – 280 .
   PubMed Web of Science ®Google Scholar
• Thurston , G . 2003 . Role of angiopoietins and tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis . Cell Tissue Res , 314 : 61 – 68 .
   PubMed Web of Science ®Google Scholar
• Adhami , V M , Ahmad , N and Mukhtar , H . 2003 . Molecular targets for green tea in prostate cancer prevention . J Nutr , 133 : 2417S – 2424S .
   PubMed Web of Science ®Google Scholar
• Wang , S I and Mukhtar , H . 2002 . Gene expression profile in human prostate LNCaP cancer cells by (−)-epigallocatechin-3-gallate . Cancer Lett , 182 : 43 – 51 .
   PubMed Web of Science ®Google Scholar
• Scaltriti , M , Belloni , L , Caporali , A , Davalli , P and Remondini , D . 2006 . Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling . Carcinogenesis , 27 : 1047 – 1053 .
   PubMed Web of Science ®Google Scholar
• Bettuzzi , S , Rizzi , F and Belloni , L . 2007 . Clinical relevance of the inhibitory effect of green tea catechins (GtCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view . Pol J Vet Sci , 10 : 57 – 60 .
   PubMed Web of Science ®Google Scholar
• Duhon , D , Bigelow , R L , Coleman , D T , Steffan , J J and Yu , C . 2010 . The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells . Mol Carcinog , 49 : 739 – 749 .
   PubMed Web of Science ®Google Scholar
• Zhong , H , Chiles , K , Feldser , D , Laughner , E and Hanrahan , C . 2000 . Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics . Cancer Res , 60 : 1541 – 1545 .
   PubMed Web of Science ®Google Scholar
• Beltz , L A , Bayer , D K , Moss , A L and Simet , I M . 2006 . Mechanisms of cancer prevention by green and black tea polyphenols . Anticancer Agents Med Chem , 6 : 389 – 406 .
   PubMedGoogle Scholar
• Khan , N , Afaq , F , Saleem , M , Ahmad , N and Mukhtar , H . 2006 . Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate . Cancer Res , 66 : 2500 – 2505 .
   PubMed Web of Science ®Google Scholar
• Lin , J K , Liang , Y C and Lin-Shiau , S Y . 1999 . Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade . Biochem Pharmacol , 58 : 911 – 915 .
   PubMed Web of Science ®Google Scholar
• Pandey , M and Gupta , S . 2009 . Green tea and prostate cancer: from bench to clinic . Front Biosci (Elite Ed) , 1 : 13 – 25 .
   PubMedGoogle Scholar
• Saleem , M , Adhami , V M , Siddiqui , I A and Mukhtar , H . 2003 . Tea beverage in chemoprevention of prostate cancer: a mini-review . Nutr Cancer , 47 : 13 – 23 .
   PubMed Web of Science ®Google Scholar
• Baud , V and Karin , M . 2009 . Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls . Nat Rev Drug Discov , 8 : 33 – 40 .
   PubMed Web of Science ®Google Scholar
• Dutta , J , Fan , Y , Gupta , N , Fan , G and Gelinas , C . 2006 . Current insights into the regulation of programmed cell death by NF-kappaB . Oncogene , 25 : 6800 – 6816 .
   PubMed Web of Science ®Google Scholar
• Lee , C H , Jeon , Y T , Kim , S H and Song , Y S . 2007 . NF-kappaB as a potential molecular target for cancer therapy . Biofactors , 29 : 19 – 35 .
   PubMed Web of Science ®Google Scholar
• Sardana , G , Dowell , B and Diamandis , E P . 2008 . Emerging biomarkers for the diagnosis and prognosis of prostate cancer . Clin Chem , 54 : 1951 – 1960 .
   PubMed Web of Science ®Google Scholar
• Thomas , R and Kim , M H . 2005 . Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells . Biochem Biophys Res Commun , 334 : 543 – 548 .
   PubMed Web of Science ®Google Scholar
• Zhou , Y D , Kim , Y P , Li , X C , Baerson , S R and Agarwal , A K . 2004 . Hypoxia-inducible factor-1 activation by (−)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts . J Nat Prod , 67 : 2063 – 2069 .
   PubMed Web of Science ®Google Scholar
• Stuart , E C , Scandlyn , M J and Rosengren , R J . 2006 . Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer . Life Sci , 79 : 2329 – 2336 .
   PubMed Web of Science ®Google Scholar
• Chow , H H , Hakim , I A , Vining , D R , Crowell , J A and Tome , M E . 2007 . Modulation of human glutathione s-transferases by polyphenon e intervention . Cancer Epidemiol Biomarkers Prev , 16 : 1662 – 1666 .
   PubMed Web of Science ®Google Scholar
• Yang , C S , Lambert , J D , Hou , Z , Ju , J and Lu , G . 2006 . Molecular targets for the cancer preventive activity of tea polyphenols . Mol Carcinog , 45 : 431 – 435 .
   PubMed Web of Science ®Google Scholar
• Fang , M Z , Wang , Y , Ai , N , Hou , Z and Sun , Y . 2003 . Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines . Cancer Res , 63 : 7563 – 7570 .
   PubMed Web of Science ®Google Scholar
• Chen , L and Zhang , H Y . 2007 . Cancer preventive mechanisms of the green tea polyphenol (−)-epigallocatechin-3-gallate . Molecules , 12 : 946 – 957 .
   PubMed Web of Science ®Google Scholar
• Yang , K , Fan , K , Newmark , H , Leung , D and Lipkin , M . 1996 . Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets . Cancer Res , 56 : 4644 – 4648 .
   PubMed Web of Science ®Google Scholar
• Pandey , M and Gupta , S . 2007 . Green tea polyphenols inhibit promoter hypermethylation through the downregulation of DNMT expression in prostate cancer LNCaP cells . Paper presented at 98th AACR Annual Meeting . April 14–18 2007 , Los Angeles , CA .
   Google Scholar